Resources

Type of publications
Regions
Diseases

5192 results found

2018 ∙ Milligan, R. Paul, M. Richardson, M. Neuberger, A.

Vaccines for preventing typhoid fever

  • Children
  • Adolescents
  • Adults
  • Typhoid
  • Safety
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2018 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, October 2018 – Conclusions and recommendations

  • Meeting report
  • Measles
  • Poliomyelitis
Download:
2018 ∙ SAGE

What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seronegative individuals 9-16 years of age in the first year following vaccination?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seropositive individuals 9-16 years of age in the first year following vaccination?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

Should countries considering introduction of CYD-TDV to reduce the burden of dengue use a pre-vaccination screening or population seroprevalence based criteria?

  • Evidence to recommendation table
  • Dengue
Download:
2018 ∙ SAGE

Should CYD-TDV be recommended, over no vaccination, to immunocompetent individuals (≥9 years of age) in dengueendemic countries to mitigate the dengue burden of disease?

  • Evidence to recommendation table
  • Dengue
Download:
2018 ∙ SAGE

What is the duration of protection/risk in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

What is the duration of protection/risk in seronegative individuals 9-16 years of age vaccinated with CYD-TDV?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

What is the risk of other serious adverse events (non-dengue) in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

Dengue vaccine: WHO position paper

  • Position paper
  • Dengue
Download:
Loading...